Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate vs propofol for general anesthesia
NCT03921775Phase 3Completed
- Sponsor
- Hengrui
- Start
- May 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of remimazolam in general anesthesia (2 arms), sponsored by Hengrui. Primary endpoint: Percentage of participants who experienced successful anesthesia during operation at 2 hours. Started May 2019; status: completed.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT03921775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03921775.